Based on the expression of estrogen, progesterone, HER2, and Ki67 receptors, BC can be classified into intrinsic subtypes such as luminal A or luminal B, triple-negative breast cancer (TNBC), and HER2-enriched tumors based on their gene expression profile. This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.